Salish Bioscience Inc. — Form D
Salish Bioscience Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-14. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-04-14
- Form: D
- Accession: 0001922451-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 25
- Date of first sale: 2022-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-441884
Issuer
- Name: Salish Bioscience Inc.
- CIK: 0001922451
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2021
- Address: 3005 1st Avenue Suite 204, SEATTLE, WA, 98121
- Phone: 2068496038
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kira Misura | Director | Seattle, WA |
| Frank Paganelli | Director | Woodinville, WA |
| Chris Raymond | Director | Seattle, WA |
| Fenella Raymond | Director | Seattle, WA |
| Frank Paganelli | Executive Officer | Woodinville, WA |
| Fenella Raymond | Executive Officer | Seattle, WA |
More